Amdocs Limited (NASDAQ:DOX – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the five analysts that are presently covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $92.3333.
DOX has been the topic of several research analyst reports. Stifel Nicolaus cut their price objective on Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday, February 4th. Barclays lowered their target price on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a research note on Wednesday, February 4th. Wall Street Zen cut shares of Amdocs from a “buy” rating to a “hold” rating in a report on Saturday, March 21st. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Amdocs in a report on Tuesday, January 27th.
Read Our Latest Analysis on DOX
Amdocs Trading Down 1.2%
Amdocs (NASDAQ:DOX – Get Free Report) last announced its earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.75 by $0.06. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.The business had revenue of $1.16 billion during the quarter, compared to analyst estimates of $1.15 billion. During the same quarter in the previous year, the business earned $1.66 earnings per share. The company’s revenue for the quarter was up 4.1% compared to the same quarter last year. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. On average, analysts anticipate that Amdocs will post 6.21 earnings per share for the current fiscal year.
Amdocs Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.569 per share. This is a boost from Amdocs’s previous quarterly dividend of $0.53. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.28 dividend on an annualized basis and a yield of 3.5%. Amdocs’s dividend payout ratio is presently 40.81%.
Hedge Funds Weigh In On Amdocs
Several institutional investors have recently made changes to their positions in DOX. Harbor Capital Advisors Inc. bought a new position in Amdocs during the 3rd quarter worth about $26,000. Root Financial Partners LLC bought a new stake in shares of Amdocs in the 3rd quarter valued at about $26,000. WealthCollab LLC lifted its position in shares of Amdocs by 94.5% in the 3rd quarter. WealthCollab LLC now owns 356 shares of the technology company’s stock worth $29,000 after purchasing an additional 173 shares during the period. Atlantic Union Bankshares Corp purchased a new stake in shares of Amdocs in the 3rd quarter worth approximately $37,000. Finally, BOK Financial Private Wealth Inc. bought a new position in shares of Amdocs during the fourth quarter valued at approximately $37,000. Hedge funds and other institutional investors own 92.02% of the company’s stock.
About Amdocs
Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.
Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.
Featured Stories
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
